Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?

Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?

A list of Top 10 Small-Cap Stocks with Highest Upside Potential includes REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotech firm focusing on gene therapy. Analysts predict a 226.

Read More

Did you find this insightful?